Introduction {#s1}
============

In all eukaryotes, transport between the nucleus and the cytoplasm is channeled through nuclear pore complexes (NPCs) embedded within the nuclear envelope ([@bib84]; [@bib12]). Yeast NPCs are approximately 60 MDa ([@bib18]) and are composed of multiple copies of about 30 nucleoporins ([@bib71]). Cargos of different sizes and charges pass through the central transport channel of the NPC, which is filled with a meshwork of natively unfolded Phe-Gly (FG)-repeats present in FG-nucleoporins ([@bib21]; [@bib83]). These nucleoporins generate a permeability barrier that allows passive diffusion of small molecules, such as ions and metabolites ([@bib21]; [@bib61]). Macromolecules (\>40 kDa) require the assistance of nuclear transport receptors, including members of the importin-β-like family, to efficiently overcome this selectivity barrier ([@bib48]; [@bib67]; [@bib70]). These transport receptors, also termed importins and exportins, mediate the majority of molecular exchange between the nucleus and cytoplasm ([@bib10]). Transport receptors recognize their cargo via specific signal sequences ([@bib11]; [@bib87]; [@bib29]) and translocate them through the NPC by transiently interacting with FG-repeats.

The small GTPase Ran coordinates the movement of importins and exportins between the nucleus and the cytoplasm, and directs the compartment-specific binding and release of transported cargos ([@bib22]; [@bib62]; [@bib10]). Ran exists in both GDP- and GTP-bound forms, and the two states are asymmetrically distributed, with RanGTP significantly enriched in the nucleus ([@bib57]; reviewed in [@bib26]). This gradient of RanGTP is established through the spatial separation of regulators of the Ran-cycle ([@bib35]). Whereas the Ran guanine nucleotide exchange factor, RCC1 (Prp20 in yeast) ([@bib9]; [@bib19]), localizes to the nucleus, the Ran GTPase-activating protein, RanGAP1 (Rna1 in yeast), is found in the cytoplasm ([@bib33]; [@bib49]). Interactions between RanGTP and transport receptors are crucial for the directionality of nucleocytoplasmic exchange ([@bib56]). In the nucleus, RanGTP induces the release of imported cargos from importins ([@bib66]; [@bib27]). In addition, RanGTP promotes the interaction of cargos with exportins for their transport to the cytoplasm ([@bib20]; [@bib42]; [@bib81]; [@bib80]).

In budding yeast, ribosome assembly accounts for a major proportion of the nucleocytoplasmic transport ([@bib72]; [@bib74]; [@bib82]; [@bib41]; [@bib76]). mRNAs encoding ribosomal proteins (r-proteins) are exported into the cytoplasm. Newly synthesized r-proteins are imported into the nucleus and then targeted to the nucleolus for incorporation into nascent pre-ribosomes ([@bib76]). Additionally, \>300 transiently interacting non-ribosomal assembly factors aid the construction and maturation of ribosomes ([@bib4]; [@bib14]; [@bib28]; [@bib73]; [@bib25]). Correctly assembled pre-ribosomal particles are transported through NPCs into the cytoplasm ([@bib85]; [@bib60]). In addition to other cargos, it is estimated that each yeast NPC facilitates the export of ∼25 pre-ribosomal particles every minute ([@bib86]). Transporting pre-ribosomal cargos from the nucleus through the NPC into the cytoplasm, therefore, represents a major task for the export machinery.

The Ran-cycle-dependent exportin Crm1 plays an essential role in exporting pre-ribosomal particles to the cytoplasm ([@bib34]; [@bib54]; [@bib23]; [@bib37]). Crm1 recognizes and directly binds leucine-rich nuclear export signals (NESs) on cargos in the presence of RanGTP to form a Crm1-export complex ([@bib20]). Although an essential NES-containing adaptor, Nmd3, has been identified for 60S pre-ribosome export ([@bib31]; [@bib32]; [@bib23]), a similar adaptor to recruit Crm1 to the 40S pre-ribosome remains elusive. It has been suggested that multiple NES-containing adaptors such as Ltv1 and Rio2 recruit Crm1 ([@bib77]; [@bib90]; [@bib51]), thereby guaranteeing efficient 40S pre-ribosome export. The essential mRNA and 60S pre-ribosome transport receptor Mex67-Mtr2, which does not directly utilize the RanGTP gradient, also facilitates nuclear export of the 40S pre-ribosomal cargo ([@bib17]). Despite the identification of several components of the export machinery, assembly steps and mechanisms that prepare the pre-ribosomal cargo for transport through the NPC remain largely unexplored.

To initiate export, Crm1 must cooperatively bind RanGTP and its NES-containing cargo in the nucleus, to form a trimeric export complex ([@bib63]; [@bib13]; [@bib53]). NESs have evolved to maintain relatively low affinity to Crm1 to avoid defects in disassembly of the export complex in the cytoplasm ([@bib15]; [@bib43]). Mechanisms that promote Crm1-export complex assembly and thereby ensure export of the NES-containing cargo at a reasonable rate remain poorly understood.

Here, we identify yeast Slx9 as a new type of RanGTP-binding protein that promotes assembly of a Crm1-export complex on the 40S pre-ribosome-associated NES-containing adaptor Rio2. Our data raise the possibility of a yet-unidentified family of RanGTP-binding proteins that act as scaffolds to optimally present RanGTP and NES-containing cargos to Crm1, orchestrating a non-cooperative stepwise assembly that drives fast and efficient Crm1-mediated export.

Results {#s2}
=======

*slx9-1* causes defects in 40S pre-ribosome nuclear export {#s2-1}
----------------------------------------------------------

Slx9 is a 24-kDa basic protein that co-enriches with pre-ribosomal particles in the 40S maturation pathway ([@bib24]; [@bib17]) and is required for efficient nuclear export of 40S pre-ribosomes ([@bib45]; [@bib17]). However, the precise contribution of Slx9 to 40S pre-ribosome export has remained unclear. To investigate the function of yeast Slx9, we generated *slx9* variants by random mutagenesis and analyzed the growth of the resulting strains at different temperatures. One allele, *slx9L108P*, hereafter termed *slx9-1*, caused slow growth at temperatures between 20°C and 30°C, indistinguishable from *slx9∆* cells ([Figure 1A](#fig1){ref-type="fig"}, top panel). Like *slx9∆*, *slx9-1* cells were not impaired in growth at 37°C ([Figure 1A](#fig1){ref-type="fig"}). Western analysis of whole cell lysates revealed that Slx9 and Slx9-1 were present at similar levels ([Figure 1A](#fig1){ref-type="fig"}, bottom panel), indicating that impaired growth of the *slx9-1* strain is not due to reduced levels of the mutant protein. As previously observed, Slx9-GFP localized primarily to the nucleolus, where it co-localized with the nucleolar marker Gar1-mCherry, as well as to the nucleoplasm ([@bib17] and [Figure 1B](#fig1){ref-type="fig"}). Slx9-1-GFP displayed an identical localization ([Figure 1B](#fig1){ref-type="fig"}), indicating that the mutant protein is correctly targeted to the nucleolus and nucleoplasm. Slx9 maximally co-enriched with Enp1-TAP that purifies both the 90S and 40S pre-ribosomes ([@bib17]). A similar purification from *slx9-1* cells revealed that Enp1-TAP co-enriched at least as much Slx9-1 mutant protein as Slx9 ([Figure 1C](#fig1){ref-type="fig"}). Together, these data show that Slx9-1 is correctly expressed, localized, and recruited to 40S pre-ribosomes.10.7554/eLife.05745.003Figure 1.*slx9*-1 phenocopies the *slx9∆* mutation.(**A**) The *slx9-1* allele does not complement the slow growth of *slx9∆* cells. Top: *SLX9*, *slx9∆*, and *slx9-1* cells were spotted in 10-fold dilutions on SD-plates and grown at the indicated temperatures for 3--6 days. Bottom: Slx9 protein levels from whole cell extracts derived from the indicated strains were determined by Western analysis using antibodies directed against Slx9. Levels of the protein Arc1 served as a loading control. (**B**) Slx9-1 localizes to the nucleolus/nucleoplasm. Cells expressing Gar1-mCherry and Slx9-GFP or Slx9-1-GFP were grown until mid-log phase. Localization of the indicated fusion proteins was analyzed by fluorescence microscopy. Gar1-mCherry served as a nucleolar marker. Scale bar = 5 µm. (**C**) Slx9-1 is recruited to the early 40S pre-ribosome. Enp1-TAP was isolated by tandem affinity purification (TAP) from the indicated strains. Calmodulin-eluates were separated on a 4--12% gradient gel and analyzed by either silver staining or Western using the indicated antibodies. The ribosomal protein uS7 served as a loading control. (**D**) *slx9-1* cells are impaired in nuclear export of 40S pre-ribosomes. Top: localization of uS5-GFP was monitored by fluorescence microscopy. Bottom: localization of 20S pre-rRNA was analyzed by FISH using a Cy3-labeled oligonucleotide complementary to the 5′ portion of ITS1 (red). Nuclear and mitochondrial DNA was stained by DAPI (blue). Scale bar = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.003](10.7554/eLife.05745.003)

Previous studies showed that *slx9∆* cells accumulate the small subunit reporter uS5-GFP (yeast Rps2, nomenclature according to [@bib3]) and 20S pre-rRNA in the nucleoplasm ([@bib45]; [@bib17]), indicating a defect in 40S pre-ribosome export. Using these reporters, we tested whether *slx9-1* cells have defects in 40S pre-ribosome export. Whereas WT cells displayed cytoplasmic uS5-GFP localization, *slx9-1* cells showed a strong nuclear accumulation of this reporter, similar to that observed in *slx9∆* cells ([@bib17] and [Figure 1D](#fig1){ref-type="fig"}, top panel). As expected, fluorescence in situ hybridization (FISH) of 20S pre-rRNA in WT cells showed a strong nucleolar Cy3-ITS1 signal (red) with virtually no nucleoplasmic staining. In contrast, *slx9-1* cells displayed a nucleoplasmic signal of Cy3-ITS1 localization, which co-localized with the DAPI signal ([Figure 1D](#fig1){ref-type="fig"}, bottom panel). These data indicate that *slx9-1* cells, like *slx9∆* cells ([@bib17]), are impaired in 40S pre-ribosome export. Therefore, we conclude that Slx9-1 is recruited to the 40S pre-ribosome but fails to fulfill its function in nuclear export of the pre-ribosomal cargo.

Slx9 is a shuttling RanGTP-binding protein {#s2-2}
------------------------------------------

Mutations in *MEX67* and *MTR2* (*mex67*Δ*loop* and *mtr2*Δ*loop116-137*), which encode the essential transport receptor Mex67-Mtr2, are synthetically lethal when combined with the *slx9*Δ mutant ([@bib17]). In addition, we found that *slx9∆* displayed a synthetic growth defect with a strain expressing Rrp12-GFP ([Figure 2A](#fig2){ref-type="fig"}). Rrp12 is a 40S pre-ribosome export factor that directly interacts with FG-rich nucleoporins ([@bib59]). Based on these genetic interactions, we asked whether Slx9 functions as a novel export factor for the 40S pre-ribosome. A salient feature of an export factor is that it rapidly shuttles between the nucleus and the cytoplasm. To test this, we employed the established heterokaryon assay ([@bib2]). WT cells expressing Slx9-GFP were mated to *kar1-1* cells, which are deficient in nuclear fusion after cell conjugation, leading to heterokaryon formation. In order to distinguish between the two nuclei, *kar1-1* cells also contained Nup82-mCherry as a marker for nuclear pores. As controls, we used the shuttling 40S assembly factor Enp1 and the non-shuttling nucleolar protein Gar1 fused to GFP. Whereas Gar1-GFP was never seen in the nucleus of *kar1-1* cells (red signal), both Enp1-GFP and Slx9-GFP localized to both nuclei ([Figure 2B](#fig2){ref-type="fig"}). These data are consistent with the shuttling of Slx9 between the nuclear and the cytoplasmic compartments.10.7554/eLife.05745.004Figure 2.Slx9 is a RanGTP binding protein.(**A**) *slx9-1* genetically interacts with factors involved in 40S pre-ribosome export. *slx9-1* is synthetically lethal with *mex67∆loop*, *mtr2∆loop116-137*, or *yrb2∆* and strongly synthetically enhanced with *rrp12-GFP*. Strains containing the indicated WT and mutant alleles were spotted in 10-fold serial dilutions on 5-FOA-SD or SD and grown at 20--30°C for 3--6 days. (**B**) Slx9 shuttles between the nucleus and the cytoplasm. Cells expressing Enp1-GFP, Gar1-GFP, or Slx9-GFP were mated with *kar1-1* cells expressing Nup82-mCherry. The resulting heterokaryons were analyzed by fluorescence microscopy. Scale bar = 5 µm. (**C**) Slx9 directly binds to RanGTP. GST-Slx9 or GST-Ssb1C was immobilized on GSH-Sepharose before incubating with either buffer alone or buffer containing 2 µM His~6~-Ran^QL^GTP, 50 nM Crm1-His~6~ or 2 µM His~6~-Ran^QL^GTP, and 50 nM Crm1-His~6~. After washing, bound proteins were eluted in LDS sample buffer, separated by SDS-PAGE and visualized by Coomassie staining or Western blotting using the indicated antibodies. L = input. (**D**) Slx9 specifically interacts with the GTP-bound form of Ran. GST-Slx9, GST-Yrb1, or GST-Ntf2 was immobilized on GSH-Sepharose and incubated with buffer alone or 2 µM His~6~-Ran loaded with GDP or GTP. Analysis of the eluted proteins was carried out as described in (**C**). L = input. (**E**) Slx9-1 binding to RanGTP is impaired. Top: GST-Slx9 or GST-Slx9-1 immobilized on GSH-Sepharose was incubated with buffer alone or 2 µM His~6~-Ran^QL^GTP. Analysis of the eluted proteins was carried out as described in (**C**). L = input. Bottom: bar graph depicts the bound His~6~-Ran^QL^GTP Western blot signal normalized to GST-Slx9 and GST-Slx9-1 levels, respectively. Four independent experiments were performed and Western blots were quantified by software ImageJ (Version 1.44o). Error bars (S.D.) are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.004](10.7554/eLife.05745.004)

We wondered whether Slx9 functions directly in 40S pre-ribosome export as a NES-containing adaptor for the exportin Xpo1 (hereafter termed Crm1). We, therefore, investigated whether Slx9 binds Crm1 in the presence of Gsp1Q71L ([@bib50]) in vitro (equivalent to the human RanQ69L GTP-stabilized mutant, hereafter termed Ran^QL^GTP; [@bib8]). The C-terminal domain of Ssb1 (Ssb1C) that contains a functional NES ([@bib78]) served as a positive control. Unlike Ssb1C ([@bib50] and [Figure 2C](#fig2){ref-type="fig"}, lane 8), Slx9 was unable to form a trimeric export complex with Crm1 and Ran^QL^GTP ([Figure 2C](#fig2){ref-type="fig"}, lane 4). Surprisingly, these studies revealed that Slx9 directly bound Ran^QL^GTP ([Figure 2C](#fig2){ref-type="fig"}, lane 2 and 4). Therefore, although Slx9 does not contain a functional NES, it is a Ran-binding protein.

Since Slx9 is a shuttling protein, we tested whether Slx9 interacts with both RanGTP and RanGDP in vitro. As controls, we used Ntf2, the import factor for RanGDP ([@bib68]; [@bib79] and [Figure 2D](#fig2){ref-type="fig"}, lane 8) and the yeast RanBP1 homolog Yrb1 that binds to RanGTP ([@bib75] and [Figure 2D](#fig2){ref-type="fig"}, lane 6). We found that, like Yrb1, Slx9 interacted exclusively with RanGTP ([Figure 2D](#fig2){ref-type="fig"}, lanes 2 and 3). Based on these data, we conclude that Slx9 is a shuttling RanGTP-binding protein.

Slx9-1 is impaired in binding Ran^QL^GTP {#s2-3}
----------------------------------------

The *slx9-1* mutant did not rescue the slow growth and impaired 40S pre-ribosome export of *slx9∆* cells ([Figure 1A](#fig1){ref-type="fig"}). Furthermore, like *slx9∆* cells, *slx9-1* cells genetically interacted with *mex67* and *mtr2* mutants (*mex67∆loop* and *mtr2∆116-137*) and *rrp12-GFP* ([Figure 2A](#fig2){ref-type="fig"}). These findings prompted us to test whether Slx9-1 binds to Ran^QL^GTP in vitro, using the assay described above. We found a decrease of approximately 50% in the levels of Ran^QL^GTP bound to Slx9-1 as compared to Slx9 ([Figure 2E](#fig2){ref-type="fig"}). Based on these data, we conclude that Slx9-1 is modestly impaired in binding Ran^QL^GTP.

The basic patch of RanGTP contributes to Slx9 binding {#s2-4}
-----------------------------------------------------

A conserved basic patch on Ran is involved in the interaction with known Ran-binding proteins ([@bib58]). Based on homology to human Ran, arginine 142, and lysine 143 in yeast Ran were mutated to alanine (Ran^QL^GTP^RKAA^) or glutamate (Ran^QL^GTP^RKEE^) and the contribution of this basic patch to Slx9:RanGTP complex formation was analyzed in vitro. In agreement with previous studies ([@bib58]), these Ran^QL^GTP mutants bound weakly to the importin β-like transport receptor, Kap123 ([Figure 3A](#fig3){ref-type="fig"}, compare lane 10 with lanes 11 and 12), and interacted more strongly with the RanBP1 homolog Yrb1 ([Figure 3A](#fig3){ref-type="fig"}, compare lane 6 with lanes 7 and 8). Pull down studies of Slx9 and these Ran mutants showed that the interactions between Slx9 and these two Ran mutants were impaired, with the charge reversal mutant having a more severe effect than the alanine mutant ([Figure 3A](#fig3){ref-type="fig"}, compare lane 2 with lanes 3 and 4). Altogether, these results suggest that, similar to Kap123, Slx9 binding to Ran^QL^GTP involves the basic patch.10.7554/eLife.05745.005Figure 3.The basic patch and acidic tail of Ran modulates interactions with Slx9.(**A**) The basic patch of Ran~QL~GTP contributes to Slx9 binding. GST-Slx9, GST-Yrb1, or GST-Kap123 immobilized on GSH-Sepharose was incubated with buffer alone or 2 µM Ran (His~6~-Ran^QL^GTP, His~6~-Ran^QL^GTP^RKAA^, or His~6~-Ran^QL^GTP^RKEE^). After washing, bound proteins were eluted in LDS sample buffer, separated by SDS-PAGE and visualized by Coomassie staining or Western blotting using the indicated antibody. L = input. (**B**) The acidic tail of Ran^QL^GTP negatively regulates interactions with Slx9. GST-Slx9, GST-Yrb1, or GST-Kap123 immobilized on GSH-Sepharose was incubated with buffer alone or 2 µM Ran (His~6~-Ran^QL^GTP or His~6~-Ran∆C^QL^GTP). Analysis of the eluted proteins was carried out as described in (**A**). L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.005](10.7554/eLife.05745.005)

The acidic C-terminal tail of Ran reduces Slx9-binding {#s2-5}
------------------------------------------------------

The C-terminal acidic tail of Ran (-DEDDAL) plays a crucial role in the interaction with small RanGTP-binding proteins such as Yrb1. As expected, Ran^QL^GTP lacking the C-terminal acidic tail (Ran∆C^QL^ GTP) failed to interact with Yrb1 in vitro ([@bib50] and [Figure 3B](#fig3){ref-type="fig"}, lane 6). We tested whether the acidic tail contributes to the interaction between RanGTP and Slx9. In contrast to Yrb1, Ran∆C^QL^GTP bound stronger to Slx9 compared to Ran^QL^GTP ([Figure 3B](#fig3){ref-type="fig"}, compare lane 2 and 3). This enhanced interaction was specific, since Kap123 bound Ran∆C^QL^GTP and Ran^QL^GTP to a similar extent ([Figure 3B](#fig3){ref-type="fig"}, compare lanes 8 and 9). These data suggest that the C-terminal acidic tail of Ran negatively regulates RanGTP:Slx9 interactions.

*SLX9* genetically interacts with the RanGTP- and Crm1-binding protein Yrb2 {#s2-6}
---------------------------------------------------------------------------

Cells lacking the RanGTP- and Crm1-binding protein Yrb2 (*yrb2*Δ) exhibit strong nucleoplasmic accumulation of uS5-GFP and 20S pre-rRNA as well as reduced abundance of 40S subunits ([@bib55]; [@bib1]). In addition, *mex67*Δ*loop* and *mtr2*Δ*loop116-137* are synthetically lethal with *yrb2*Δ ([@bib17]). These findings led us to test whether *SLX9* genetically interacts with *YRB2*. Both *slx9∆* and *slx9-1* were synthetically lethal with *yrb2∆* ([Figure 2A](#fig2){ref-type="fig"}), suggesting that Slx9 and Yrb2 functionally overlap to ensure proper nuclear export of 40S pre-ribosomes.

Slx9 binds the NES-containing 40S pre-ribosomal adaptor Rio2 {#s2-7}
------------------------------------------------------------

Yrb2 and its human homolog, RanBP3, stimulate the assembly of Crm1-export complexes on certain NES-containing cargos by cooperatively binding Crm1 and RanGTP ([@bib16]; [@bib46]; [@bib40]). The strong genetic interaction between *SLX9* and *YRB2* raised the possibility that Slx9 also functions in Crm1-complex assembly. However, our interaction studies showed that Slx9 binds RanGTP, but not Crm1 ([Figure 2C](#fig2){ref-type="fig"}, lane 4). We, therefore, wondered whether Slx9 instead facilitates the assembly of a Crm1-export complex by bringing together RanGTP and the NES-containing adaptor.

Two 40S pre-ribosome-associated factors, hLtv1 and hRio2, have been shown to bind Crm1 in the presence of RanGTP ([@bib90]). In agreement with these studies, we found that yeast Ltv1 and yeast Rio2 formed trimeric complexes with Crm1 and Ran^QL^GTP via a cooperative mechanism in vitro ([Figure 4A](#fig4){ref-type="fig"}, lanes 4 and 12). Moreover, the C-terminal regions of these proteins are predicted to contain a NES ([@bib90]; [@bib51] and [Figure 4A](#fig4){ref-type="fig"}, top panel), and indeed, Rio2 and Ltv1 mutant proteins lacking NESs were unable to form trimeric export complexes ([Figure 4A](#fig4){ref-type="fig"}, lanes 8 and 16). Western analyses revealed that Rio2, but not Ltv1, interacted weakly with Ran^QL^GTP, independent of Crm1 ([Figure 4A](#fig4){ref-type="fig"}, lane 2).10.7554/eLife.05745.006Figure 4.Slx9 directly binds the 40S pre-ribosome nuclear export signal (NES)-containing adaptor Rio2 and Ran^QL^GTP.(**A**) Rio2 and Ltv1 export complex formation requires their C-terminal NESs. Top: the positions of the Rio2 and Ltv1 NESs are shown. Hydrophobic residues in these NESs are highlighted in red. Bottom: GST-Rio2, GST-Rio2^∆NES^, GST-Ltv1, or GST-Ltv1^∆NES^ was immobilized on GSH-Sepharose, and complex formation was analyzed as in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**B**) Slx9 directly interacts with Rio2. Immobilized GST-Rio2 or GST-Ltv1 was incubated with buffer alone or 0.5 µM Slx9. Conversely, immobilized GST-Slx9 was incubated with buffer alone or with lysate containing His~6~-Nmd3 or His~6~-Rio2. Analysis of the eluted proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.006](10.7554/eLife.05745.006)

Ltv1 and Rio2 co-enrich with the Enp1-TAP particle that also maximally co-purifies Slx9 ([Figure 1C](#fig1){ref-type="fig"}; [@bib76]) suggesting that these NES-containing proteins might interact with Slx9. To test this, we incubated immobilized GST-Rio2 or GST-Ltv1 with Slx9. Slx9 directly bound to Rio2 but not to Ltv1 ([Figure 4B](#fig4){ref-type="fig"}, left panel). Conversely, GST-Slx9 interacted with Rio2 but not with the essential 60S pre-ribosome-associated NES-containing adaptor Nmd3 ([Figure 4B](#fig4){ref-type="fig"}, right panel). Moreover, the GST-Rio2:Slx9 complex efficiently recruited Ran^QL^GTP ([Figure 5A](#fig5){ref-type="fig"}). The level of recruitment was not affected by the prior presence or absence of Slx9, since GST-Rio2 saturated with Slx9 recruited similar amounts of Ran^QL^GTP ([Figure 5B](#fig5){ref-type="fig"}, compare top and bottom panels). Also, the levels of Ran^QL^GTP recruitment to GST-Slx9 were not affected by the presence or absence of Rio2 ([Figure 5C](#fig5){ref-type="fig"}, compare top and bottom panels). Altogether, these data suggest that Rio2 binds Slx9 and Ran^QL^GTP using distinct surfaces.10.7554/eLife.05745.007Figure 5.Slx9 binds to Rio2 and RanGTP using distinct binding surfaces.(**A**) GST-Rio2 was immobilized on GSH-Sepharose and incubated with buffer, 2 µM His~6~-Ran^QL^GTP, or 0.5 µM Slx9 (+^1^). After washing, the GST-Rio2:Slx9 complex was incubated with 2 µM His~6~-Ran^QL^GTP (+^2^). Analysis of the eluted proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**B**) RanGTP does not displace Slx9 from a preformed GST-Rio2:Slx9 complex. Top: immobilized GST-Rio2 was incubated with buffer or increasing concentrations of His~6~-Ran^QL^GTP (62.5 nM--32 µM). Bottom: immobilized GST-Rio2 was incubated with either buffer or 1 µM Slx9. The unbound Slx9 was washed away, and the resulting GST-Rio2:Slx9 complex was incubated with increasing concentrations of His~6~-Ran^QL^GTP (62.5 nM--32 µM). Analysis of the eluted proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**C**) Ran^QL^GTP does not displace Rio2 from a preformed GST-Slx9:Rio2 complex. Top: immobilized GST-Slx9 was incubated with buffer or increasing concentrations of His~6~-Ran^QL^GTP (62.5 nM--32 µM). Bottom: immobilized GST-Slx9 was incubated with excess of Rio2. The unbound Rio2 was washed away, and the resulting complex GST-Slx9:Rio2 complex was incubated with increasing concentrations of His~6~-Ran^QL^GTP (62.5 nM--32 µM). Analysis of the eluted proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.007](10.7554/eLife.05745.007)

Recruitment of Crm1 to Rio2:RanGTP is stimulated by Slx9 {#s2-8}
--------------------------------------------------------

We next investigated whether the GST-Rio2:Slx9:Ran^QL^GTP complex could directly recruit Crm1. To this end, pre-formed GST-Rio2:Ran^QL^GTP or GST-Rio2:Slx9:Ran^QL^GTP complexes (summarized in [Figure 6A](#fig6){ref-type="fig"}) were incubated with buffer alone or Crm1 ([Figure 6B](#fig6){ref-type="fig"}, lanes 3, 4 and 7, 8). Only the GST-Rio2:Slx9:Ran^QL^GTP complex efficiently recruited Crm1 ([Figure 6B](#fig6){ref-type="fig"}, compare lanes 4 and 8). The Crm1-recruitment to a GST-Rio2:Slx9:Ran^QL^GTP complex was dependent on the NES of Rio2, since a GST-Rio2^∆NES^:Slx9:Ran^QL^GTP complex was unable to bind Crm1 ([Figure 6B](#fig6){ref-type="fig"}, compare lanes 8 and 10). Moreover, Crm1 recruitment was also dependent on the Ran^QL^GTP bound to Rio2, since a GST-Rio2:Slx9 complex was unable to bind Crm1 ([Figure 6C](#fig6){ref-type="fig"}, lane 4). These studies indicate that, in order to recruit Crm1 in a non-cooperative manner, Rio2 must bind to both Slx9 and RanGTP.10.7554/eLife.05745.008Figure 6.Slx9 promotes stepwise assembly of a Crm1-export complex on the NES of Rio2.(**A**) Flow chart depicting the experimental setup to assemble a Rio2:Slx9:Ran^QL^GTP:Crm1 complex. Immobilized GST-Rio2 was sequentially incubated with Slx9 (red), Ran^QL^GTP (purple), and Crm1 (green). Unbound protein was washed away after each incubation step. (**B**) Crm1 is recruited to the GST-Rio2:Slx9:RanGTP complex in a NES-dependent manner. Immobilized GST-Rio2 or GST-Rio2^∆NES^ was incubated with buffer alone or 0.5 µM Slx9, followed by the stepwise addition of 0.2 µM His~6~-Ran^QL^GTP and 50 nM Crm1-His~6~, as depicted in (**A**). After a final washing step, bound proteins were analyzed as in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**C**) Crm1 is not recruited to the GST-Rio2:Slx9 complex. Immobilized GST-Rio2 was incubated with buffer alone or 0.5 µM Slx9, followed by addition of buffer, 50 nM Crm1-His~6~, or the stepwise addition of 0.2 µM His~6~-Ran^QL^GTP and 50 nM Crm1-His~6~ as depicted in (**A**). Analysis of the bound proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**D**) Recruitment of Crm1 to a Rio2:Slx9-1:Ran^QL^GTP complex is impaired. Immobilized GST-Rio2 was incubated with buffer alone, 0.5 µM Slx9 or 0.5 µM Slx9-1, followed by the stepwise addition of 0.2 µM His~6~-Ran^QL^GTP and 50 nM Crm1-His~6~ as depicted in (**A**). Analysis of the bound proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.008](10.7554/eLife.05745.008)

We next investigated whether Slx9-1 could assemble a GST-Rio2:Slx9-1:Ran^QL^GTP complex. In vitro binding studies revealed that Rio2 binds Slx9-1 ([Figure 6D](#fig6){ref-type="fig"}, lane 6). In comparison to the Slx9, Slx9-1 bound at least as well to Rio2 ([Figure 6D](#fig6){ref-type="fig"}, compare lane 2 and 6). Further, the GST-Rio2:Slx9-1 complex was also able to recruit Ran^QL^GTP ([Figure 6D](#fig6){ref-type="fig"}, lane 7), indicating that Slx9-1 is still able to assemble a GST-Rio2:Slx9-1:Ran^QL^GTP complex. However, this complex was impaired in loading Crm1 ([Figure 6D](#fig6){ref-type="fig"}, compare lane 5 and 9). Therefore, we suggest that Slx9 promotes assembly of a Crm1-export complex on Rio2, and that this function relies on a proper interaction between Slx9 and RanGTP.

Slx9 acts as a scaffold to load Crm1 onto the Rio2-NES {#s2-9}
------------------------------------------------------

Crm1 recognizes and binds cargos that contain diverse leucine-rich NESs. Structural analyses of the RanGTP:Crm1 complex bound to prototypic NESs suggest that any peptide can function as a NES as long as its backbone conformation permits its side chains to access the rigid hydrophobic pockets of Crm1 ([@bib30]). To test whether conformational rigidity of the Rio2-NES is critical to recruit Crm1 in the presence of Ran^QL^GTP, three consecutive residues (399-EEN-401) proximal to the NES were mutated to glycines (Rio2^3G^) ([Figure 7A](#fig7){ref-type="fig"}, top panel). Because glycine residues lack a side chain, they allow greater conformational flexibility for the polypeptide backbone of these residues ([@bib65]) as well as to the neighboring NES, thus destabilizing it. We found that, like the Rio2^∆NES^ ([Figure 4A](#fig4){ref-type="fig"}, lane 8), Rio2^3G^ was unable to cooperatively recruit Crm1 in the presence of Ran^QL^GTP in vitro ([Figure 7A](#fig7){ref-type="fig"}, bottom panel, lane 4). In parallel, we made a Rio2 mutant in which residues 399--401 were replaced by alanines (Rio2^3A^) ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, top panel). Unlike Rio2^3G^ ([Figure 7A](#fig7){ref-type="fig"}, bottom panel, lane 4), Rio2^3A^ was able to efficiently cooperatively recruit Crm1 in the presence of Ran^QL^GTP ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}, bottom panel), suggesting that the glycine mutations destabilize the NES.10.7554/eLife.05745.009Figure 7.Slx9 provides a scaffold to load Crm1 onto Rio2-NES.(**A**) Rio2^3G^ does not interact with Crm1 in the presence of RanGTP. Top: schematic depicts the positions of mutations proximal to the NES (399-EEN-401-GGG) in the Rio2^3G^. Hydrophobic amino acids of the NES are red and mutated amino acids are orange. Bottom: GST-Rio2^3G^ was immobilized on GSH-Sepharose and binding reactions were carried out and analyzed as in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**B**) *rio2∆NES*, but not *rio2*^*3G*^, is synthetically lethal with *mex67∆loop* and *mtr2∆loop116-137*. Strains were spotted in 10-fold serial dilutions on 5-FOA (SD) plates and grown at 30°C for 2--4 days. (**C**) Slx9 restores Crm1 binding to the Rio2^3G^:Slx9:Ran^QL^GTP complex. GST-Rio2:Slx9:Ran^QL^GTP or GST-Rio2^3G^:Slx9:Ran^QL^GTP was incubated with buffer alone or 50 nM Crm1-His~6~. Bound proteins were analyzed as in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**D**) Crm1 is impaired in binding a Rio2^3G^:Slx9-1:Ran^QL^GTP complex. Immobilized GST-Rio2^3G^ was incubated with buffer alone, 0.5 µM Slx9 or 0.5 µM Slx9-1, followed by the stepwise addition of 0.2 µM His~6~-Ran^QL^GTP and 50 nM Crm1-His~6~ as depicted in (**A**). Analysis of the bound proteins was carried out as described in [Figure 2C](#fig2){ref-type="fig"}. L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.009](10.7554/eLife.05745.009)10.7554/eLife.05745.010Figure 7---figure supplement 1.The 'flexibility' of the NES region in Rio2 contributes to its interaction with Crm1 in the presence of RanGTP.Top: schematic of Rio2 highlighting the triple A mutation (399-EEN-401-AAA, brown) proximal to the NES. Hydrophobic amino acids of the NES are red and mutated amino acids are brown. Bottom: immobilized GST-Rio2^3A^ was incubated with buffer alone or buffer containing 2 µM His~6~-Ran^QL^GTP, 50 nM Crm1-His~6~ or 2 µM His~6~-Ran^QL^GTP, and 50 nM Crm1-His~6~. After washing, eluted proteins were separated by SDS-PAGE and visualized by Coomassie staining or Western blotting using indicated antibodies. L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.010](10.7554/eLife.05745.010)10.7554/eLife.05745.011Figure 7---figure supplement 2.Genetic interactions between Rio2 alleles and RanGTP-binding proteins Slx9 and Yrb2.(**A**) *slx9∆* and *slx9-1* do not genetically interact with *rio2∆NES*. A *RIO2* shuffle *slx9∆* strain was transformed with the indicated combinations of empty, WT, or mutant plasmids and spotted in 10-fold dilutions on SD-plates containing 5-FOA and grown at 25°C for 2--4 days. (**B**) *rio2∆NES* weakly genetically interacts with *yrb2∆*. *RIO2* shuffle *yrb2∆* strain transformed with the indicated combinations of empty, WT or mutant plasmids were spotted in 10-fold dilutions on SD-plates containing 5-FOA and grown at 25°C for 2--4 days.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.011](10.7554/eLife.05745.011)

We next assessed the functionality of Rio2^∆NES^ and Rio2^3G^ in yeast. Both *rio2∆NES* and *rio2*^*3G*^ rescued the lethality of the *rio2∆* strain ([Figure 7B](#fig7){ref-type="fig"}). However, *rio2∆NES* was synthetically lethal mex67∆loop and *mtr2∆116-137* ([Figure 7B](#fig7){ref-type="fig"}), consistent with the model that the transport receptor Mex67-Mtr2 has a redundant function in 40S pre-ribosome nuclear export. Curiously, the *rio2*^*3G*^ allele that did not recruit Crm1 in the presence of Ran^QL^GTP in vitro ([Figure 7A](#fig7){ref-type="fig"}, bottom panel, lane 4), rescued the synthetic lethality ([Figure 7B](#fig7){ref-type="fig"}), indicating that Rio2^3G^ is still functional in vivo. Importantly, neither *rio2* alleles (*rio2∆NES* and *rio2*^*3G*^) were synthetic lethal when combined with *slx9∆* and *slx9-1* mutant strains ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}).

These genetic interactions led us to ask whether Slx9 could stabilize the NES conformer of Rio2^3G^ to facilitate Crm1 recruitment. To test this, a GST-Rio2^3G^:Slx9:Ran^QL^GTP complex was incubated with Crm1. Remarkably, this complex was able to recruit Crm1 similar to the Rio2:Slx9:Ran^QL^GTP complex ([Figure 7C](#fig7){ref-type="fig"}, compare lane 2 and 4). Notably, we found that the GST-Rio2^3G^:Slx9-1:Ran^QL^GTP complex was impaired in loading Crm1 ([Figure 7D](#fig7){ref-type="fig"}, compare lane 1 and 2). Altogether, these data suggest that, within the GST-Rio2^3G^:Slx9:Ran^QL^GTP complex, Slx9 promotes Crm1 loading by stabilizing the region surrounding the Rio2-NES.

Strong NESs on Rio2 bypass the requirement for Slx9 {#s2-10}
---------------------------------------------------

Our data so far show that a specific mutation within Slx9 impaired Crm1-export complex assembly in vitro and 40S pre-ribosome export in vivo. We, therefore, wondered whether replacing the Rio2-NES with a set of strong NESs could bypass the requirement of Slx9 in 40S pre-ribosome export. The strength of a specific NES is based on its resemblance to the consensus sequence and has been shown to strongly correlate with its affinity for Crm1 in vitro ([@bib15]; [@bib43]). To this end, we replaced the Rio2-NES with the strong NESs of Nmd3 (hereafter termed as Rio2^Nmd3NES^) ([@bib15]; [@bib43]).

Functional analyses revealed that the expression of Rio2^Nmd3NES^ complemented the lethality of the *rio2∆* strain. Moreover, *rio2-nmd3NES* was not synthetic lethal with *mex67∆loop* and *mtr2∆116-137* ([Figure 8A](#fig8){ref-type="fig"}). Since Rio2^Nmd3NES^ bound to Crm1 in the presence of RanGTP ([Figure 8B](#fig8){ref-type="fig"}, lane 4), we assessed whether Rio2^Nmd3NES^ expression rescued the 40S pre-ribosome export defect seen in *slx9∆* cells. \>95% of *slx9∆* cells expressing Rio2 and Rio2^∆NES^ accumulated uS5-GFP in the nucleoplasm. However, *slx9∆* cells expressing Rio2^Nmd3NES^ did not accumulate uS5-GFP in the nucleoplasm ([Figure 8C](#fig8){ref-type="fig"}), indicating no apparent impairment in 40S pre-ribosome export. A Rio2 variant containing only the first NES of Nmd3 (*rio2-nmd3NES∆1*) was unable to rescue the 40S pre-ribosome export defect of *slx9∆* cells ([Figure 8C](#fig8){ref-type="fig"}), suggesting that both NESs are required to bypass Slx9 function in 40S pre-ribosome export. Notably, the expression of Rio2^Nmd3NES^ in *yrb2∆* cells did not rescue the nucleoplasmic accumulation of uS5-GFP ([Figure 8D](#fig8){ref-type="fig"}), indicating that the heterologous NESs specifically bypasses Slx9 function but not other steps that drive 40S pre-ribosome export.10.7554/eLife.05745.012Figure 8.Strong NESs of Nmd3 on Rio2 bypass requirement for Slx9 but not Yrb2 in 40S pre-ribosome export.(**A**) *rio2-nmd3NES* is not synthetic lethal with *mex67∆loop* or *mtr2∆loop116-137*. Strains were spotted in 10-fold serial dilutions on 5-FOA (SD) plates and grown at 30°C for 2--4 days (**B**) The Nmd3-NES (amino acids 440--518) fused to Rio2^∆NES^ bypasses the requirement of the Rio2-NES in export complex formation in vitro. GST-Rio2^Nmd3NES^ was immobilized on GSH-Sepharose and complex formation was carried out and analyzed as in [Figure 2C](#fig2){ref-type="fig"}. L = input. (**C**) *rio2-nmd3NES* rescues the impaired pre40S export of *slx9∆* cells. Localization of uS5-GFP in the indicated strains was monitored by fluorescence microscopy. Scale bar = 5 µm. (**D**) The rescue of impaired pre40S ribosome export by *rio2-nmd3NES* is specific for *slx9∆*. *yrb2∆* cells transformed with the indicated plasmids was monitored by fluorescence microscopy for the localization of uS5-GFP. Scale bar = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.012](10.7554/eLife.05745.012)

Discussion {#s3}
==========

In order to mediate nuclear export of NES-containing cargos, Crm1 must form trimeric complexes with these cargos and RanGTP. To allow efficient cargo release in the cytoplasm, NESs have evolved to have low affinity for Crm1 ([@bib15]; [@bib43]). This low affinity is expected to reduce the efficiency of Crm1-export complex formation and slow down nuclear export ([@bib15]). Despite their low affinity in vitro, NES-containing cargos are exported efficiently in vivo ([@bib43]). Because they are amongst the most abundant export cargos in a eukaryotic cell and require rapid, sustained rates of export; pre-ribosomal particles are particularly sensitive to the interactions between the NES and Crm1 ([@bib89]; [@bib60]). Here, we identify Slx9 as a RanGTP-binding protein that stabilizes the interaction between RanGTP, Rio2, and Crm1 without promoting cooperative binding between these proteins. Instead, Slx9 overcomes the low affinity between the NES and Crm1 and drives stepwise assembly of a Crm1-export complex on the NES-containing adaptor Rio2 of the 40S pre-ribosomal cargo.

Slx9 is a new type of RanGTP-binding protein required for 40S pre-ribosome export {#s3-1}
---------------------------------------------------------------------------------

Slx9 was first proposed to function in ribosome biogenesis pathway through promoting ITS1 processing, which is required to separate pre-rRNAs of the large and small pre-ribosomal subunits ([@bib5]). In support to this early assembly role, *slx9∆* interacts genetically with mutations in *RRP5*, which encodes an assembly factor required for pre-rRNA processing. However, low-copy overexpression of the transport receptor *MEX67-MTR2*, which is involved in 40S pre-ribosome export, suppresses the growth defect and pre-40S export defect of *slx9∆* cells. Further, *SLX9* genetically interacts with several factors directly involved in 40S pre-ribosome export ([@bib17]). These functional studies indicate a role for Slx9 in the nuclear export of the 40S pre-ribosomal cargo ([@bib17]). Thus, the pre-rRNA processing defects observed in the *slx9∆* mutant could be a consequence of a primary defect in the nuclear export of 40S pre-ribosomes.

Surprisingly, although Slx9 did not interact with Crm1 in vitro, it interacts specifically with the GTP-bound form of Ran. This interaction depends on the basic patch of RanGTP. Removal of the RanGTP acidic C-terminal tail strengthened Slx9:RanGTP interactions, suggesting that these proteins interact in a manner distinct from previously identified RanGTP-binding proteins, such as Yrb1 ([@bib50]; [@bib58]). Sequence analyses did not reveal any apparent homology between Slx9 and known Ran-binding proteins. Based on all these data, we propose that Slx9 is a new type of RanGTP-binding protein.

Slx9 mediates non-canonical stepwise assembly of a Crm1-export complex {#s3-2}
----------------------------------------------------------------------

To assemble a Crm1-export complex, Crm1 requires binding to both RanGTP and a NES-containing cargo in a cooperative manner ([@bib13]; [@bib29]; [@bib53]). This canonical assembly pathway requires Crm1 to switch from a relaxed, low affinity 'cytoplasmic' conformation to a strained, high-affinity 'nuclear' conformation. In the nuclear conformation, RanGTP is enclosed within the toroid-like fold of Crm1, away from the cargo-binding site. Structural analyses of Crm1-complexes suggest that RanGTP promotes NES-binding solely by stabilizing the strained nuclear conformation of Crm1 ([@bib29]; [@bib53]).

In contrast, Slx9 mediates a non-canonical stepwise assembly of a Crm1-export complex. First, Slx9 binds RanGTP and the NES-containing 40S pre-ribosome adaptor Rio2. Interactions between Slx9, Rio2, and RanGTP do not rely on cooperative binding, since the pairwise complexes between these proteins were stable. However, all three proteins were required for efficient Crm1 loading to the Rio2-NES. This recruitment also does not rely on cooperative binding between Rio2, Crm1, and RanGTP, since the Slx9:Rio2:RanGTP complex was stable in the absence of Crm1.

Mutational and functional studies identified a point mutation, L108P, which impaired the ability of Slx9 to bind RanGTP in vitro. Although this mutant protein was stably recruited to pre-ribosomal particles in vivo and to Rio2 in vitro, it was unable to assemble a Crm1-export complex. Both *slx9∆* and *slx9-1* cells displayed impaired 40S pre-ribosome export and synthetic phenotypes with factors involved in 40S pre-ribosome export. These data suggest that the 40S pre-ribosome nuclear export defect observed in *slx9∆* and *slx9-1* cells is due to their failure to efficiently assemble Crm1-export complexes on 40S pre-ribosomal particles. A stepwise formation of a Crm1-export complex could allow currently uncharacterized quality control surveillance steps to monitor pre-ribosome assembly and ensure that only correctly assembled particles are chosen for export. In this respect, Slx9-dependent ribosome export would mirror the assembly process of the 40S pre-ribosomal cargo itself.

Crm1-mediated nuclear export is modulated by RanGTP-binding proteins, which promote specific steps along the export pathway. For example, RanBP3/Yrb2 increases the rate of cooperative Crm1-complex assembly in the nucleus ([@bib40]). Yrb2/RanBP3 also modulates Crm1 substrate recognition, promoting interactions with certain NESs and preventing the strong Crm1-Snurportin1 interaction ([@bib16]; [@bib44]). At the other end of the export cycle, RanBP1/Yrb1 and RanBP2 interact strongly with RanGTP in the cytoplasm to stimulate Crm1-export complex disassembly, thereby indirectly contributing to export efficiency ([@bib7]; [@bib38]; [@bib50]). Notably, despite the fact that these RanGTP-binding proteins act at different stages to stimulate export, they typically influence cooperative interaction between cargo, Crm1, and RanGTP.

Slx9 utilized a distinct mechanism from that proposed for Yrb2/RanBP3 for Crm1-export complex assembly ([@bib16]; [@bib46]; [@bib40]). Yrb2/RanBP3 increases the affinity of Crm1 for RanGTP by stabilizing a conformation of Crm1 that promotes canonical assembly of a Crm1-export complex ([@bib44]; [@bib40]). In contrast, Slx9 does not interact with RanGTP and Crm1 to form a complex. Instead, it interacts with RanGTP and the NES-containing adaptor Rio2. Finally, biochemical and structural studies show that Yrb2 competes with NES-containing cargo for binding to Crm1 and suggest that NES-binding causes partial dissociation of Yrb2 from the complex ([@bib40]). In contrast, Slx9 remains stably bound to the GST-Rio2:Crm1:RanGTP complex, suggesting that it does not compete with the Rio2-NES for its interaction. Despite these clear differences, both Slx9 and RanBP3/Yrb2 work to overcome the low binding affinity between NESs and Crm1, representing distinct solutions to the paradox of low affinity interactions driving fast and efficient Crm1-mediated cargo export. Notably, *SLX9* strongly genetically interacted with *YRB2*, suggesting that both mechanisms are employed to ensure rapid 40S pre-ribosome export.

Does Slx9 target other NES-containing cargos? Although *slx9∆* showed a strong 40S pre-ribosome export defect, *rio2∆NES* grew indistinguishably from WT cells. Notably, *rio2∆NESyrb2∆* cells grew slowly ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}) but are not synthetically lethal as the *slx9∆yrb2∆* strain. These genetic interactions argue that Rio2 is not the sole target of Slx9. Genetic approaches will uncover additional NES-containing adaptors that employ Slx9 to prepare the 40S pre-ribosome for nuclear export.

A family of NES-conformer stabilizers? {#s3-3}
--------------------------------------

NESs contain variability in the spacing between key hydrophobic residues, yet are recognized by the same rigid hydrophobic pockets on Crm1 ([@bib30]). The structure of RanGTP-Crm1 bound to prototypic NESs showed that the backbone of NESs adopts different conformations, which permits the efficient insertion of key NES residues ([@bib30]). In support of the proposed NES-conformer selection model, a destabilized NES of Rio2^3G^ was unable to bind Crm1 in the presence of RanGTP in vitro. However, Crm1 recruitment to Rio2^3G^ was restored in the presence of Slx9, suggesting a stabilizing function. This stabilization provides a mechanism to overcome the weak binding of NESs to Crm1, driving Crm1-complex assembly and guaranteeing efficient cargo export into the cytoplasm. One prediction of the NES-conformer selection model would be that NESs with favorable conformations exhibit improved affinity to Crm1. Slx9 may belong to a family of yet-unidentified RanGTP-binding proteins that induce and stabilize NES-conformers upon binding export cargos. Thus, these RanGTP-binding proteins would allow greater NES variability and potentially regulate the efficiency by which specific NESs are recognized by Crm1.

Materials and methods {#s4}
=====================

Yeast strains and plasmids {#s4-1}
--------------------------

Yeast strains used in this study are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Genomic disruptions, insertion of C-terminal tags, and promotor switches at genomic loci were performed as previously described ([@bib47]; [@bib64]; [@bib36]). Preparation of media, yeast transformations, and genetic manipulations were performed accordingly to established procedures. Genetic analyses were performed as previously described ([@bib17]).

Plasmids used in this study are listed in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. All recombinant DNA techniques were performed accordingly to established procedures using *Escherichia coli* XL1 blue cells for cloning and plasmid propagation.

*rio2∆NES* was created by deletion of the DNA sequence encoding the last 12 amino acids of Rio2. *ltv1∆NES* was created by removing the last 13 amino acids. The *rio2-nmd3NES* was created by fusion of the C-terminal region of *NMD3* encoding amino acids 440--518 to *rio2∆NES*. *rio2-nmd3NES∆1* was created by fusing *NMD3* lacking amino acids 440--487. The C-terminal DNA-fragment of *SSB1* (*SSB1C*) encodes the amino acids 524--613 ([@bib50]).

Point mutations in *SLX9*, *RIO2*, or *GSP1* were generated using the QuikChange site-directed mutagenesis kit (Agilent Technologies, Switzerland). All cloned DNA fragments generated by PCR amplification and mutagenized plasmids were verified by sequencing.

Biochemical analysis {#s4-2}
--------------------

Tandem affinity purifications (TAPs) of pre-ribosomal particles were carried out as previously described ([@bib17]; [@bib2]). Calmodulin eluates were separated on NuPAGE 4--12% Bis-Tris gradient gels (Invitrogen, Zug, Switzerland). Separated proteins were visualized by either silver staining or Western analysis using indicated antibodies.

Whole cell lysates were prepared by a modified post-alkaline extraction protocol as previously described ([@bib39]). Extracted proteins were separated by SDS-PAGE. Proteins were visualized by Western blotting using the indicated antibodies.

Western analyses were performed as previously described ([@bib39]). The following primary antibodies were used: α-Slx9 (1:3000; [@bib17]), α-Arc1 (1:4000; E Hurt, University of Heidelberg, Heidelberg, Germany), α-Xpo1 (Crm1) (1:3000; this study), α-His (1:2000; Sigma--Aldrich, USA), α-uS7 (yeast Rps5; 1:4000; Proteintech Group Inc., Chicago, IL, USA), α-TAP (CBP) (1:4000; Thermo Scientific, Rockford, IL, USA), α-Ltv1 (1:5000; K Karbstein, Scripps Research Institute, Jupiter, FL, USA), α-Rio2 (1:1000; Proteintech Group Inc.), α-Tsr1 (1:5000; K Karbstein, Scripps Research Institute), and α-Gsp1 (Ran) (1:3000; this study). For detection, HRP-conjugated α-rabbit (1:2000--1:4000; Sigma--Aldrich) or α-mouse secondary antibodies (1:2000--1:4000; Sigma--Aldrich) were applied. Signals were visualized using the Immun-Star HRP chemiluminescence kit (Bio-Rad Laboratories, Hercules, CA, USA) and captured by Fuji Super RX X-ray films (Fujifilm, Japan).

Recombinant protein expression and in vitro binding studies {#s4-3}
-----------------------------------------------------------

Recombinant Slx9 and Slx9-1, Rio2, Rio2 variants, and Xpo1 (yeast Crm1) were expressed in *E. coli* BL21 upon IPTG induction (final concentration 0.3 mM). His~6~-tagged proteins were affinity purified in purification buffer (50 mM Tris-HCl, 200 mM NaCl, 10 mM Imidazole, 1 mM β-mercaptoethanol, pH 8), using Ni-NTA agarose (GE Healthcare, Uppsala, Sweden). The GB1-His-domains of these proteins were removed by TEV cleavage. All proteins were stored in PBS-KMT (150 mM NaCl, 25 mM sodium phosphate, 3 mM KCl, 1 mM MgCl~2~, 0.1% Tween, pH 7.3) after buffer exchange. GST-fusion proteins were purified in PBSKMT using GSH-Sepharose (GE Healthcare). His~6~-Gsp1 (Ran) WT and mutants were expressed and purified as previously described ([@bib80]; [@bib50]).

For in vitro binding studies, recombinant GST-tagged proteins were immobilized on GSH-Sepharose (GE Healthcare) in PBSKMT and incubated with the indicated proteins for 1 hr at 4°C. Binding studies between GST-tagged Slx9, Yrb1, or Kap123 and Ran variants were performed as described before ([@bib80]). To prevent nonspecific interactions, all binding assays were carried out in the presence of competing *E. coli* lysates.

Trimeric export complex formation between GST-tagged Slx9, Rio2, or Ltv1 variants and His~6~-Ran^QL^GTP and/or Crm1-His~6~ was adapted and modified from [@bib69] and [@bib80]. Immobilized GST-fusion proteins were incubated with buffer alone or buffer containing 2 µM His~6~-Ran^QL^GTP or 50 nM Crm1-His~6~ or 2 µM His~6~-Ran^QL^GTP and 50 nM Crm1-His~6~.

The interactions between GST-fusions of Slx9, Ntf2, and Yrb1 and RanGTP or RanGDP were analyzed as follows: first, His~6~-Ran was incubated with GDP or GTP (50× molar excess of the protein concentration) in the presence of 6 mM EDTA in KP~i~ buffer (24.8 mM KH~2~PO~4~, 25 mM, K~2~HPO~4~, 20 mM KCl, 5 mM MgCl~2~, 2 mM Imidazole, 5 mM β-mercaptoethanol, pH 6.8) on ice for 40 min. This incubation step was terminated by the addition of 0.3 mM MgCl~2~. In the second step, 2 µM Ran (GTP or GTP) was incubated with immobilized GST-fusion proteins for 1 hr at 4°C.

To form a Rio2:Slx9:Ran:Crm1 complex, GST-Rio2 variants were immobilized on GSH-Sepharose and incubated with buffer alone or 2 µM purified Slx9 variants for 1 hr at 4°C.Then, samples were incubated with 0.2 µM purified His~6~-Ran^QL^GTP for 1 hr at 4°C. In the last step, samples were incubated with buffer alone or 50 nM purified Crm1-His~6~. After each incubation step, unbound proteins were removed by three times washing with PBSKMT.

All bound proteins were eluted in LDS-sample buffer (Invitrogen) and separated by SDS-PAGE. Separated proteins were visualized by Coomassie staining or by Western analysis using antibodies against Slx9, Crm1, or Ran. 1/3 of bound proteins and 1/3--3× of input were analyzed on a Coomassie gel. 1/6 of bound proteins and 1/24 (Slx9) or 1/50 (Ran, Crm1, Nmd3, and Rio2) of the input was used for Western analysis.

Fluorescence microscopy and heterokaryon assay {#s4-4}
----------------------------------------------

Cells were visualized using a DM6000B microscope (Leica, Germany) equipped with a HCX PL Fluotar 63×/1.25 NA oil immersion objective (Leica). Images were acquired with a fitted digital camera (ORCA-ER; Hamamatsu Photonics, Japan) and Openlab software (Perkin--Elmer, USA).

Localization of pre-40S subunits was monitored employing the uS5-GFP reporter construct as previously described ([@bib17]; [@bib2]). Co-localization of Slx9-GFP and Slx9-1-GFP with Gar1-mCherry was done as previously described ([@bib17]).

The heterokaryon assay was adapted and modified from ([@bib6]; [@bib1]). Briefly, equal amounts of cells expressing Enp1-GFP, Gar1-GFP, or Slx9-GFP were mated with *kar1-1* cells expressing Nup82-mCherry and concentrated onto 0.45-µM nitrocellulose filter. Mixtures were placed on YPD plates containing 50 µM cycloheximide. After 1 hr incubation at 30°C, cells were analyzed by fluorescence microscopy.

FISH {#s4-5}
----

Localization of 20S pre-rRNA in the different strains was analyzed using a Cy3-labeled oligonucleotide probe (5′-Cy3-ATG CTC TTG CCA AAA CAA AAA AAT CCA TTT TCA AAA TTA TTA AAT TTC TT-3′) that is complementary to the 5′ portion of ITS1 as described ([@bib17]; [@bib2]).
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The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This manuscript describes the largely uncharacterized protein Slx9 as a cofactor for Crm1-mediated nuclear export of pre-40S subunits. Whereas much is known about export of the large ribosomal subunit, export of the small subunit has remained enigmatic. It is well established that it depends on Crm1 but essential Crm1 ligands have not been identified. This has led to the suggestion that export factors for the small subunit are redundant. In this work, the authors identify Slx9 as a factor that interacts with Ran-GTP and the NES-containing pre-40S factor Rio2 to recruit Crm1. The data are clearly presented and, for the most part, support the general claims of the authors. However, there are several inconsistencies in the data and interpretation that warrant clarification. While many of these can probably be handled by additional explanations, two points are likely to require new experiments. First, the conclusion of a ternary complex of Slx9-RanGTP-Rio2 is not strongly supported. Second, quantitative interaction analysis rather than the more qualitative GST-pulldown is warranted for certain conclusions. Finally, the text could benefit from a more balanced tone that limits overstatements and overinterpretation of some of the data. Some suggestions are provided in the comments below.

1\) In the subsection "Recruitment of Crm1 to Rio2:RanGTP is stimulated by Slx9", the statement "...a Rio2:Slx9 complex was able to recruit RanGTP, suggesting that Slx9 employs distinct surfaces to bind these two proteins" cannot be supported strongly based on the data. The authors used immobilized Rio2 to pull down either RanGTP directly, or Slx9 followed by RanGTP. The fact they recover RanGTP in the latter could be due to its direct interaction with immobilized Rio2, either because Rio2 was not completely saturated with Slx9, or because RanGTP simply competed off some bound Slx9. It is therefore unclear how this result permits conclusion of a ternary complex. Indeed, in a situation where all pairwise combinations can interact, such GST-pulldowns will not be convincing and other methods are warranted (e.g., gel filtration, gel shift assays, or sequential affinity steps against two of the proteins recovering the third). Alternatively, a well-controlled and quantitative titration of Slx9 to show that it does not inhibit the binding of Ran-GTP could also argue against mutually exclusive binding.

2\) Subsection "Recruitment of Crm1 to Rio2:RanGTP is stimulated by Slx9": from data in [Figure 5](#fig5){ref-type="fig"} the authors claim that Slx9 promotes the formation of a complex containing Rio2, Ran-GTP and Crm1. However, [Figure 4A](#fig4){ref-type="fig"} shows that a trimeric complex containing only Rio2-Ran-GTP and Crm1 assembles efficiently in the absence of Slx9. In fact, in that complex, Crm1 appears to enhance Ran binding, suggesting cooperativity of binding. The same components appear to be present in [Figure 5B](#fig5){ref-type="fig"} lane 4 but now we do not see Crm1 binding. What accounts for this difference? This is an important point as it underpins the conclusion that Slx9 acts in a non-canonical fashion.

3\) The defective interaction between Slx9-1 and RanGTP should be analyzed biophysically to directly compare it to Slx9 (e.g., measurement of Kd values and ideally, on and off rates). The GST pulldown is rather qualitative and the modest difference in recovery observed in [Figure 2E](#fig2){ref-type="fig"} (which is not entirely convincing) cannot easily explain why this mutation essentially phenocopies a Slx9∆ strain. As this mutant is used for several key points in the paper, its characterization would appear to be important.

4\) The data presented that FAM207A is indeed the human Slx9 homolog as stated (Figure 2--figure supplement 2) is not entirely convincing. The distribution and evolutionary conservation of the Slx9 proteins has not been reported to date. Indeed, it was previously suggested that Slx9 homologs are limited to yeast species (Bax et al RNA 2006). After one referee performed some limited multiple sequence alignments between putative vertebrate FAM207A homologs and the *pombe* and *cerevisiae* Slx9 proteins, he/she did not find the level of amino acid conservation convincing. Particularly in view of the previous report (Bax et al), the authors should show evidence for the phylogenetic distribution and amino acid conservation of the Slx9 proteins beyond yeast. Related to this, the authors show that FAM207A binds Ran^QL^GTP in vitro. However, this observation in isolation is not convincing since cofractionation with ribosomes or requirement for 40S subunit export are not analyzed. The authors should either be more cautious about the claim that FAM207A is the functional human Slx9 homolog or more robustly support this conclusion.

5\) In [Figure 2B](#fig2){ref-type="fig"}, the authors must rule out that newly synthesized protein does not account for the apparent shuttling of Slx9. Notably, the signal for Slx9 in the recipient nucleus seems less than that for the positive control of Enp1.

Minor comments:

1\) In their previous paper ([@bib17]) the Panse group show that at 37 °C, slx9Δ yeast cells grow almost like wild type with restoration of 40S subunit export. How do the authors square this apparent paradox with the findings reported in the current manuscript? Do cells carrying the slx9-1 allele also show restoration of 40S export at 37 °C? Are the proposed "weak" binding events such as the Rio2-Crm1 interaction temperature-dependent?

2\) How does the proposed role of Slx9 in Crm1-mediated nuclear export relate to the previously reported role of Slx9 in ITS1 pre-rRNA processing (Bax et al RNA 2006)? This previous work has not been referenced and should be discussed in the text.

3\) I am a little confused by the data in [Figure 2E](#fig2){ref-type="fig"} and [Figure 5C](#fig5){ref-type="fig"}. In [Figure 2E](#fig2){ref-type="fig"}, the authors claim that the interaction between GST-Slx9-1 and His6-Ran^QL^GTP is reduced compared with wild type GST-Slx9. However, to my eye, there seems to be less GST-Slx9-1 compared with GST-Slx9. Indeed, in contrast with [Figure 2E](#fig2){ref-type="fig"}, Slx9 and Slx9-1 seem to bind similarly to Ran^QL^GTP in [Figure 5C](#fig5){ref-type="fig"}. Is this apparent difference in Slx9-1-Ran^QL^GTP binding due to the presence of Rio2 in [Figure 5C](#fig5){ref-type="fig"}?

4\) There is a lot of discussion in the text about "weak" (Rio2) and "strong" (Nmd3) NES sequences in Crm1-mediated export. Can the authors define this more quantitatively.

5\) In [Figure 1](#fig1){ref-type="fig"} the authors report that slx9-1 localizes to the nucleolus, like the wild-type protein but they claim that it blocks export, evidenced by accumulation of pre-40S markers in the nucleoplasm. If Slx9-1 loads onto particles but prevents their recruitment, its localization should be coincident with the pre-40S markers. How do the authors explain this discrepancy?

6\) The authors identified *slx9-1* as a loss of function mutant and showed that it had reduced interaction with Ran-GTP. In light of that, it is surprising that it appears to bind more tightly to Rio2 and recruit higher levels of Ran-GTP. How can this be explained?

7\) The authors should explain what the biophysical property of GGG is and how they imagine this will affect the presentation of the NES. What do they mean that the GGG mutant "destabilizes" the NES?

8\) [Figure 5C](#fig5){ref-type="fig"} is intended to show that Slx9-1 interacts more strongly than Slx9 (i.e., lane 6 versus 2, respectively). While this is apparent on the immunoblot, inspection of the stained gel reveals little if any difference. Similarly, the input lanes show Slx9 and Slx9-1 at seemingly equal levels on the stained gel, yet give clearly different signals by immunoblot. This raises the somewhat worrisome possibility that differences see in [Figure 1C](#fig1){ref-type="fig"} (and elsewhere) are a blotting artifact, which is remarkably common when comparing proteins that migrate differently or are mutated. Such potential discrepancies are worth clarifying.

9\) In the subsection "Slx9 acts as a scaffold to load Crm1 onto the Rio2-NES", the authors state that the RanGTP binding site of Slx9 plays a role in recruiting Crm1, but the basis for this claim is not clear given that the authors do not know what/where the RanGTP binding site is on Slx9.

10\) I am not sure what the basis of the 'stepwise assembly' claim is. I realize they have often biochemically performed the reactions in a certain order, but given the various pairwise interactions that are shown in the paper, I cannot see how an order is forthcoming (beyond Crm1 arriving last). The authors should either provide a clear rationale for a specific assembly order, or remain more agnostic on the issue.

11\) The authors make a number of statements regarding kinetic parameters such as cooperativity, but I fail to see how many of these claims can be supported on the basis of relatively qualitative GST-pulldown assays.

12\) Words such as 'unexpectedly' are not all that useful in the Abstract since it is unclear what was unexpected or why, without further explanation. In general, I struggled with the repeated claims of novelty and non-canonical mechanisms when the concept appeared to this reader as a variation on that seen with RanBP3/Yrb2. A less exaggerated tone seems preferable, although I realise different authors will have different writing styles.

10.7554/eLife.05745.016

Author response

*This manuscript describes the largely uncharacterized protein Slx9 as a cofactor for Crm1-mediated nuclear export of pre-40S subunits. Whereas much is known about export of the large ribosomal subunit, export of the small subunit has remained enigmatic. It is well established that it depends on Crm1 but essential Crm1 ligands have not been identified. This has led to the suggestion that export factors for the small subunit are redundant. In this work, the authors identify Slx9 as a factor that interacts with Ran-GTP and the NES-containing pre-40S factor Rio2 to recruit Crm1. The data are clearly presented and, for the most part, support the general claims of the authors. However, there are several inconsistencies in the data and interpretation that warrant clarification. While many of these can probably be handled by additional explanations, two points are likely to require new experiments. First, the conclusion of a ternary complex of Slx9-RanGTP-Rio2 is not strongly supported. Second, quantitative interaction analysis rather than the more qualitative GST-pulldown is warranted for certain conclusions. Finally, the text could benefit from a more balanced tone that limits overstatements and overinterpretation of some of the data. Some suggestions are provided in the comments below*.

We thank the reviewers for their thorough and fair comments. We have tried to address these three points.

*1) In the subsection "Recruitment of Crm1 to Rio2:RanGTP is stimulated by Slx9", the statement "...a Rio2:Slx9 complex was able to recruit RanGTP, suggesting that Slx9 employs distinct surfaces to bind these two proteins" cannot be supported strongly based on the data. The authors used immobilized Rio2 to pull down either RanGTP directly, or Slx9 followed by RanGTP. The fact they recover RanGTP in the latter could be due to its direct interaction with immobilized Rio2, either because Rio2 was not completely saturated with Slx9, or because RanGTP simply competed off some bound Slx9. It is therefore unclear how this result permits conclusion of a ternary complex. Indeed, in a situation where all pairwise combinations can interact, such GST-pulldowns will not be convincing and other methods are warranted (e.g., gel filtration, gel shift assays, or sequential affinity steps against two of the proteins recovering the third). Alternatively, a well-controlled and quantitative titration of Slx9 to show that it does not inhibit the binding of Ran-GTP could also argue against mutually exclusive binding*.

We agree with the reviewers, and have done titrations as suggested. Specifically, we added increasing amounts of RanGTP to a preformed saturated GST-Rio2:Slx9 (or GST-Slx9:Rio2) complex. RanGTP is efficiently recruited to both GST-Rio2:Slx9 and GST-Sxl9:Rio2 complexes. Further, RanGTP binding did not displace Slx9 from the GST-Rio2:Slx9 complex (or Rio2 from GST-Slx9:Rio2). These data are now included in [Figure 5B and 5C](#fig5){ref-type="fig"}.

In addition to these experiments, we believe that two different observations strongly support the notion for distinct binding surfaces:

1\. Although Rio2 can bind RanGTP or Slx9 on its own, neither the GST-Rio2:RanGTP complex nor the GST-Rio2:Slx9 complex is competent to recruit Crm1 ([Figure 6B](#fig6){ref-type="fig"}, lane 4 and [Figure 6C](#fig6){ref-type="fig"}, lane 4). Only an immobilized GST-Rio2 that is sequentially treated with Slx9 and RanGTP can recruit Crm1 ([Figure 6B](#fig6){ref-type="fig"}, lane 8).

2\. The GST-Rio2^3G^ mutant is unable to cooperatively bind to Crm1 and RanGTP, ([Figure 7A](#fig7){ref-type="fig"}, lane 4). Only when GST-Rio2^3G^ is sequentially treated with Slx9 and then RanGTP, the resultant GST-Rio2^3G^:Slx9:RanGTP complex is now competent to recruit Crm1 ([Figure 7C](#fig7){ref-type="fig"}, lane 4).

Together these data support the idea that GST-Rio2:Slx9:RanGTP form a complex.

*2) Subsection "Recruitment of Crm1 to Rio2:RanGTP is stimulated by Slx9": From data in* [*Figure 5*](#fig5){ref-type="fig"} *the authors claim that Slx9 promotes the formation of a complex containing Rio2, Ran-GTP and Crm1. However,* [*Figure 4A*](#fig4){ref-type="fig"} *shows that a trimeric complex containing only Rio2-Ran-GTP and Crm1 assembles efficiently in the absence of Slx9. In fact, in that complex, Crm1 appears to enhance Ran binding, suggesting cooperativity of binding. The same components appear to be present in* [*Figure 5B*](#fig5){ref-type="fig"} *lane 4 but now we do not see Crm1 binding. What accounts for this difference? This is an important point as it underpins the conclusion that Slx9 acts in a non-canonical fashion*.

We agree with the reviewers that this is confusing. As the reviewers correctly points out, in [Figure 4A](#fig4){ref-type="fig"}, lane 4, Crm1 and excess RanGTP were added simultaneously to GST-Rio2. In this experiment, Rio2, RanGTP and Crm1 form a trimeric complex through a cooperative mechanism. In the absence of Crm1, RanGTP shows a weaker binding to Rio2 ([Figure 4A](#fig4){ref-type="fig"}, lane 2).

In [Figure 6B](#fig6){ref-type="fig"}, the experimental setup is different (summarized in the flow chart, [Figure 6A](#fig6){ref-type="fig"}). In a first step, RanGTP is added to GST-Rio2 and then unbound protein is washed away. Again, we observed binding to RanGTP ([Figure 6B](#fig6){ref-type="fig"}, lane 2 and 3), in agreement with [Figure 4A](#fig4){ref-type="fig"}. Then, in a second step, Crm1 is incubated with a preformed GST-Rio2:RanGTP complex ([Figure 6B](#fig6){ref-type="fig"}, lane 4). However, because Crm1 is added in the absence of excess of RanGTP, no Crm1 binding is observed. Thus, presenting Crm1 to a Rio2:RanGTP complex in an ordered fashion does not allow cooperative binding. In this stepwise mechanism, Slx9 aids Crm1 recruitment to the GST-Rio2:Slx9:RanGTP complex by optimally presenting the Rio2-NES and RanGTP.

We have altered the discussion of this data to make this distinction more clear.

*3) The defective interaction between Slx9-1 and RanGTP should be analyzed biophysically to directly compare it to Slx9 (e.g., measurement of Kd values and ideally, on and off rates). The GST pulldown is rather qualitative and the modest difference in recovery observed in* [*Figure 2E*](#fig2){ref-type="fig"} *(which is not entirely convincing) cannot easily explain why this mutation essentially phenocopies a Slx9∆ strain. As this mutant is used for several key points in the paper, its characterization would appear to be important*.

We attempted two quantitative assays, as described above: ITC and SPR. Unfortunately, these experiments were unsuccessful due to technical issues. Specifically, we were unable to attain the necessary concentrations of Slx9 and RanGTP required for ITC due to aggregation, and Slx9 displayed non-specific interactions with immobilized GST that is required to immobilize RanGTP on the surface of the SPR chip. Instead, we have quantified the binding experiment between Slx9 (or Slx9-1) and RanGTP from four independent experiments ([Figure 2E](#fig2){ref-type="fig"}). Specifically, we have normalized the RanGTP Western signal to the amount of GST-Slx9 and GST-Slx9-1 in the Coomassie-stained gel above. These quantifications confirm that GST-Slx9-1 is impaired in RanGTP binding compared to Slx9 (approximately 50% decrease). Although this is not a definitive method to measure affinity, we hope that the review agrees that the 50% reduction in binding is modest. We have tried to clarify this in the text, in the subsection headed "Slx9-1 is impaired in binding Ran^QL^GTP".

We apologize for the confusion regarding the *slx9-1* mutant phenotype. Two different complexes (outlined below) containing Slx9-1 were impaired in recruiting Crm1 in vitro. This defect is far more pronounced than the defect in Slx9-1 binding to RanGTP and, we believe that this is the major determinant of the Slx9-1 phenotype in vivo.

1\) Slx9-1 is impaired in recruiting Crm1 to the GST-Rio2:Slx9-1:RanGTP complex ([Figure 6D](#fig6){ref-type="fig"}, compare lane 5 to lane 9).

2\) The Rio2^3G^ mutant is unable to cooperatively bind to Crm1 and RanGTP ([Figure 7A](#fig7){ref-type="fig"}, lane 4). Only when bound to Slx9 and RanGTP it is now able to efficiently recruit Crm1 ([Figure 7C](#fig7){ref-type="fig"}, lane 4). Consistent with the role of Slx9 in optimally presenting the Rio2-NES to Crm1, the GST-Rio2^3G^:Slx9-1:RanGTP complex is unable to bind Crm1 ([Figure 7D](#fig7){ref-type="fig"}, compare lane 1 and 2). This additional experiment further supports the idea that Slx9 promotes Crm1 recruitment to the GST-Rio2^3G^:Slx9:RanGTP complex.

*4) The data presented that FAM207A is indeed the human Slx9 homolog as stated (Figure 2--figure supplement 2) is not entirely convincing. The distribution and evolutionary conservation of the Slx9 proteins has not been reported to date. Indeed, it was previously suggested that Slx9 homologs are limited to yeast species (Bax et al RNA 2006). After one referee performed some limited multiple sequence alignments between putative vertebrate FAM207A homologs and the* pombe *and* cerevisiae *Slx9 proteins, he/she did not find the level of amino acid conservation convincing. Particularly in view of the previous report (Bax et al), the authors should show evidence for the phylogenetic distribution and amino acid conservation of the Slx9 proteins beyond yeast. Related to this, the authors show that FAM207A binds Ran*^*QL*^*GTP in vitro. However, this observation in isolation is not convincing since cofractionation with ribosomes or requirement for 40S subunit export are not analyzed. The authors should either be more cautious about the claim that FAM207A is the functional human Slx9 homolog or more robustly support this conclusion*.

We agree with the reviewers and have removed the data concerning FAM207A from the manuscript. We originally chose FAM207A (also called C21orf70) as the potential human homolog of *S. cerevisiae* Slx9 because it is listed as the human homologue for *S. pombe* Slx9 in PomBase database (<http://www.pombase.org/spombe/result/SPAPB21F2.03>). In addition, FAM207A interacts with pre-ribosomal particles and is impaired in pre-40S export (Wyler et al., 2011 RNA). However, we have also been unable to align *S. cerevisiae* Slx9 and human FAM207A with any significance, and share the doubt that these two are not true functional homologues.

5\) In [Figure 2B](#fig2){ref-type="fig"}, the authors must rule out that newly synthesized protein does not account for the apparent shuttling of Slx9. Notably, the signal for Slx9 in the recipient nucleus seems less than that for the positive control of Enp1.

We have repeated the heterokaryon assay in presence of 50 µM cycloheximide which inhibits production of newly synthesized Slx9 protein. These data show that Slx9-GFP shuttles between the nuclear and cytoplasmic compartments ([Figure 2B](#fig2){ref-type="fig"}).

Regarding the difference in recipient nuclear signal, we suspect that there are two pools of Slx9, only one of which can shuttle. *SLX9* interacts genetically with *SGS1*, which encodes a nucleolar DNA helicase that prevents genomic instability (Ooi et al., Nature Genetics 2003). This additional nucleolar role could explain why there is only partial transfer of Slx9-GFP to the recipient nucleus. This additional role could also explain the primarily (though not exclusively) nucleolar localization of Slx9 and Slx9-1.

Minor comments:

*1) In their previous paper (*[@bib17]*) the Panse group show that at 37 °C, slx9Δ yeast cells grow almost like wild type with restoration of 40S subunit export. How do the authors square this apparent paradox with the findings reported in the current manuscript? Do cells carrying the slx9-1 allele also show restoration of 40S export at 37 °C? Are the proposed "weak" binding events such as the Rio2-Crm1 interaction temperature-dependent*?

Like the *slx9∆* mutant, the *slx9-1* allele also grows normally at 37°C and is also not impaired in the nuclear export of 40S pre-ribosomes. Indeed, this "cold-sensitive" phenotype is relatively common among ribosome synthesis factor mutants. We currently do not understand the basis of the temperature dependence, or whether the binding between Rio2 and Crm1 is temperature-dependent in vivo or, for example, whether ribosome export becomes less dependent on Rio2 at high temperatures. For completeness, we have now added the 37°C growth panel to [Figure 1A](#fig1){ref-type="fig"}.

2\) How does the proposed role of Slx9 in Crm1-mediated nuclear export relate to the previously reported role of Slx9 in ITS1 pre-rRNA processing (Bax et al RNA 2006)? This previous work has not been referenced and should be discussed in the text.

We apologize for the oversight and have now included this important reference in the Discussion. However, we believe that our data are compatible with [@bib5] RNA and that the ITS1 pre-rRNA processing defect caused by Slx9 depletion could be a secondary consequence of the primary defect in export, since the growth and the pre-40S export defect of the *slx9∆* mutant can be rescued by low copy overexpression of an additional export factor Mex67-Mtr2 ([@bib17] PLOS Genetics).

*3) I am a little confused by the data in* [*Figure 2E*](#fig2){ref-type="fig"} *and* [*Figure 5C*](#fig5){ref-type="fig"}*. In* [*Figure 2E*](#fig2){ref-type="fig"}*, the authors claim that the interaction between GST-Slx9-1 and His6-Ran*^*QL*^*GTP is reduced compared with wild type GST-Slx9. However, to my eye, there seems to be less GST-Slx9-1 compared with GST-Slx9. Indeed, in contrast with* [*Figure 2E*](#fig2){ref-type="fig"}*, Slx9 and Slx9-1 seem to bind similarly to Ran*^*QL*^*GTP in* [*Figure 5C*](#fig5){ref-type="fig"}*. Is this apparent difference in Slx9-1-Ran*^*QL*^*GTP binding due to the presence of Rio2 in* [*Figure 5C*](#fig5){ref-type="fig"}?

The reviewers are correct that these data are somewhat somehow confusing. In [Figure 2E](#fig2){ref-type="fig"}, pull down of RanGTP by GST-Slx9 or GST-Slx9-1 is shown, and Slx9-1 has a modestly reduced interaction compared to Slx9. We have resolved the issue with loading of GST-Slx9 vs. GST-Slx9-1 by quantification of four independent experiments (presented in [Figure 2E](#fig2){ref-type="fig"}). Specifically, we have normalized the RanGTP signal in the Western blot to the amount of GST-Slx9 and GST-Slx9-1 in the Coomassie-stained gel above. These quantifications confirm that GST-Slx9-1 is impaired in RanGTP binding compared to Slx9 (approximately 50% decrease). Although this is not a definitive method to measure affinity, we hope that the review agrees that the 50% reduction in binding is modest.

In [Figure 5C](#fig5){ref-type="fig"}, the immobilized protein is GST-Rio2, which has been pre-loaded with either Slx9 or Slx9-1. In this experiment, as pointed out by the reviewers, RanGTP binds equally well to both complexes. However, the complex containing GST-Rio2/Slx9-1/RanGTP is impaired in recruiting Crm1. Therefore, the reviewers are correct in that the difference between these two experiments is the presence of Rio2, which can also bind RanGTP on its own.

*4) There is a lot of discussion in the text about "weak" (Rio2) and "strong" (Nmd3) NES sequences in Crm1-mediated export. Can the authors define this more quantitatively*.

The difference in NES strength is based on the ability of Crm1 to bind the NES sequence (even without RanGTP; [@bib15] EMBO J). This interaction was shown to correlate with sequence similarity to a consensus NES sequence ([@bib15] EMBO J), and has been shown to correlate with affinity for Crm1 in vitro ([@bib43] TIBS; [@bib30] NSMB). We have altered the text both to include this historical categorization as well as acknowledged the prior work, and we apologize for the oversight.

*5) In* [*Figure 1*](#fig1){ref-type="fig"} *the authors report that slx9-1 localizes to the nucleolus, like the wild-type protein but they claim that it blocks export, evidenced by accumulation of pre-40S markers in the nucleoplasm. If Slx9-1 loads onto particles but prevents their recruitment, its localization should be coincident with the pre-40S markers. How do the authors explain this discrepancy*?

Slx9 interacts genetically with a nucleolar DNA helicase, Sgs1 that prevents genomic instability (Ooi et al, Nature Genetics 2003). This additional role which would be strictly nucleolar, would be consistent with the primarily (though not exclusively) nucleolar localization of Slx9 and Slx9-1.

*6) The authors identified* slx9-1 *as a loss of function mutant and showed that it had reduced interaction with Ran-GTP. In light of that, it is surprising that it appears to bind more tightly to Rio2 and recruit higher levels of Ran-GTP. How can this be explained*?

The reviewers are correct that, in the context of Rio2, Slx9-1 binds Ran-GTP more efficiently ([Figure 6D](#fig6){ref-type="fig"}). Our statement that Slx9-1 is impaired in RanGTP binding stems from the data shown in [Figure 2E](#fig2){ref-type="fig"}, which is a pull down of RanGTP using GST-Slx9 or GST-Slx9-1, which were performed in the absence of Rio2.

We do observe that Slx9-1 binds more strongly to Rio2 than Slx9 ([Figure 6D](#fig6){ref-type="fig"}, compare lanes 2 and 6). In addition, the GST-Rio2:Slx9-1 complex appears to bind more strongly to RanGTP than the GST-Rio2:Slx9 complex ([Figure 6D](#fig6){ref-type="fig"}, compare lanes 3 and 7). However, we also observe that Rio2 alone also binds RanGTP (eg. [Figure 6C](#fig6){ref-type="fig"}, lane 2). Since, in these experiments, there are two potential RanGTP binding sites (one on Slx9 and one on Rio2), it is difficult to conclude anything regarding the affinity between Slx9/Sxl9-1 and RanGTP in these pull downs.

7\) The authors should explain what the biophysical property of GGG is and how they imagine this will affect the presentation of the NES. What do they mean that the GGG mutant "destabilizes" the NES?

We apologize for the oversight for not explaining the use of glycine mutants clearly. Because glycine residues lack a side chain, they allow greater conformational flexibility for the polypeptide backbone of these residues (Ramachandran G N, Sasisekharan V, 1968 Adv Protein Chem) as well as to the neighboring NES, thus destabilizing it. Therefore, introduction of glycines are expected to lower the affinity of an NES for Crm1 by locally disturbing the secondary structure that is important to orient and insert the residues of the NES into the hydrophobic pockets of Crm1 ([@bib30] NSMB). A short explanation has now been included in the text.

*8)* [*Figure 5C*](#fig5){ref-type="fig"} *is intended to show that Slx9-1 interacts more strongly than Slx9 (i.e., lane 6 versus 2, respectively). While this is apparent on the immunoblot, inspection of the stained gel reveals little if any difference. Similarly, the input lanes show Slx9 and Slx9-1 at seemingly equal levels on the stained gel, yet give clearly different signals by immunoblot. This raises the somewhat worrisome possibility that differences see in* [*Figure 1C*](#fig1){ref-type="fig"} *(and elsewhere) are a blotting artifact, which is remarkably common when comparing proteins that migrate differently or are mutated. Such potential discrepancies are worth clarifying*.

We agree with the reviewers that there is a slightly stronger signal for Slx9-1 in the Western blot. We have analyzed the differences by carefully running equalized samples of the two proteins, and this difference is small, but present ([Author response image 1](#fig9){ref-type="fig"}). However, whether Slx9-1 binds slightly better to GST-Rio2 in vitro or to the pre-ribosomal particle (Enp1-TAP) in vivo ([Figure 1C](#fig1){ref-type="fig"}) does not change the major conclusion of our experiments: Slx9-1 is expressed *in vivo* and recruited to the 40S pre-ribosome. Therefore, we have altered the description of the interaction studies to say that Slx9-1 binds at least as well as the wild-type.10.7554/eLife.05745.017Author response image 1.Comparison of Coomassie staining and Western blot signals of Slx9 and Slx9-1 proteins. 0.5 µM Slx9 or 0.5 µM Slx9-1 were separated on SDS-PAGE (top panel) and either stained with Coomassie or detected by Western analysis with Slx9 antibody (lower panel). L = input.**DOI:** [http://dx.doi.org/10.7554/eLife.05745.017](10.7554/eLife.05745.017)

*9) In the subsection "Slx9 acts as a scaffold to load Crm1 onto the Rio2-NES", the authors state that the RanGTP binding site of Slx9 plays a role in recruiting Crm1, but the basis for this claim is not clear given that the authors do not know what/where the RanGTP binding site is on Slx9*.

We agree with the reviewers that we currently do not know where the RanGTP binding site is on Slx9. However, our statement regarding the impaired binding is based on the data shown in [Figure 2E](#fig2){ref-type="fig"} (which shows that Slx9-1 on its own is impaired in binding RanGTP as compared to wild-type Slx9) and the data in [Figure 6D](#fig6){ref-type="fig"}, which shows that, although the Rio2: Slx9-1 complex can recruit RanGTP, the resulting complex is significantly impaired in recruit Crm1. Since this defect is not due to the interaction between Rio2 and Slx9-1, and because Slx9 does not interact with Crm1 ([Figure 2C](#fig2){ref-type="fig"}) we propose that the defect must stem from RanGTP binding by Slx9.

*10) I am not sure what the basis of the 'stepwise assembly' claim is. I realize they have often biochemically performed the reactions in a certain order, but given the various pairwise interactions that are shown in the paper, I cannot see how an order is forthcoming (beyond Crm1 arriving last). The authors should either provide a clear rationale for a specific assembly order, or remain more agnostic on the issue*.

The stepwise assembly model that we favor is based on the *in vitro* interactions that we have identified and the cellular context in which these interactions must occur. Slx9 at steady state is localized to the nucleolus/nucleoplasm and Rio2 is nucleoplasmic/cytoplasmic (mainly cytoplasmic). Further, based on TAP purifications and Western analyses Slx9 is recruited to the earliest 40S pre-ribosome in the nucleolus. Once the pre-ribosome becomes nuclear Rio2 and RanGTP join, followed by Crm1.

11\) The authors make a number of statements regarding kinetic parameters such as cooperativity, but I fail to see how many of these claims can be supported on the basis of relatively qualitative GST-pulldown assays.

Our use of the term "cooperativity" is based on previous studies, which have shown that the binding of RanGTP and the NES containing cargo to Crm1 is cooperative i.e. the affinity for each binding partner is increased in the presence of the other. For example as shown in [Figure 2C](#fig2){ref-type="fig"}: The NES of SsbC does not bind Crm1 alone, but only in the presence of excess of RanGTP.

In this manuscript, we show that such a cooperative mechanism cannot be behind the recruitment of Crm1 to the Rio2-Slx9-RanGTP complex, since RanGTP and Crm1 are added in separate steps (so the affinity of the first protein can't be improved by the presence of the second protein). Although we have been unable to perform more quantitative binding assays, our findings support a stepwise mechanism rather than cooperativity, and therefore we believe that these assays have merit.

*12) Words such as 'unexpectedly' are not all that useful in the Abstract since it is unclear what was unexpected or why, without further explanation. In general, I struggled with the repeated claims of novelty and non-canonical mechanisms when the concept appeared to this reader as a variation on that seen with RanBP3/Yrb2. A less exaggerated tone seems preferable, although I realise different authors will have different writing styles*.

We have removed "unexpectedly" from the Abstract and altered the tone of the discussion as suggested by the reviewers.

We do not quite agree with the reviewers that the concept we are promoting is a variation to RanBP3/Yrb2 for the following reasons:

A\) Yrb2 binds RanGTP and Crm1 in a cooperative manner and then the complex is presented to the NES containing cargo. In our case, Slx9 binds RanGTP and the NES containing cargo, and this complex is able to recruit Crm1 directly.

B\) Yrb2 functions by populating the strained Crm1:RanGTP bound conformation that favors NES binding. Here, we present different mutational studies that suggest that within the Rio2:Slx9:RanGTP complex, Slx9 optimally orients the NES and improves its affinity for Crm1. For example, Rio2^3G^ mutant is unable to cooperatively bind Crm1 and RanGTP is able to do so, when in complex with Slx9.
